Literature DB >> 19357228

Measuring response with FDG-PET: methodological aspects.

Martin Allen-Auerbach1, Wolfgang A Weber.   

Abstract

The use of fluorodeoxyglucose positron emission tomography (FDG-PET) for the evaluation of tumor response to chemotherapy and radiation therapy has been studied in a number of malignancies. By imaging tumor metabolism and therapy-related changes, FDG-PET has demonstrated advantages over anatomical imaging in the assessment of treatment response. More recent investigations have indicated that FDG-PET can predict tumor response early during the course of therapy, potentially allowing for early treatment adjustments. The aim of this review is to provide oncologists with a basic knowledge of the practical aspects of PET quantification for treatment.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19357228     DOI： 10.1634/theoncologist.2008-0119

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


  25 in total

Review 1.  Imaging radiation response in tumor and normal tissue.

Authors:  Marjan Rafat; Rehan Ali; Edward E Graves
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-06-15

2.  Study of an image-derived SUV and a modified SUV using mouse FDG-PET.

Authors:  Xiujuan Zheng; Chin-Lung Yu; Wei Sha; Caius Radu; Sung-Cheng Huang; Dagan Feng
Journal:  Nucl Med Biol       Date:  2010-12-03       Impact factor: 2.408

3.  Efficient preparation and biological evaluation of a novel multivalency bifunctional chelator for 64Cu radiopharmaceuticals.

Authors:  Shuanglong Liu; Zibo Li; Li-Peng Yap; Chiun-Wei Huang; Ryan Park; Peter S Conti
Journal:  Chemistry       Date:  2011-08-04       Impact factor: 5.236

4.  Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis.

Authors:  Tejpal Gupta; Zubin Master; Sadhana Kannan; Jai Prakash Agarwal; Sarbani Ghsoh-Laskar; Venkatesh Rangarajan; Vedang Murthy; Ashwini Budrukkar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-19       Impact factor: 9.236

5.  PET/CT-Based Response Evaluation in Cancer-a Systematic Review of Design Issues.

Authors:  Oke Gerke; Karen Ehlers; Edith Motschall; Poul Flemming Høilund-Carlsen; Werner Vach
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

Review 6.  Dynamic whole-body PET imaging: principles, potentials and applications.

Authors:  Arman Rahmim; Martin A Lodge; Nicolas A Karakatsanis; Vladimir Y Panin; Yun Zhou; Alan McMillan; Steve Cho; Habib Zaidi; Michael E Casey; Richard L Wahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-29       Impact factor: 9.236

Review 7.  The role of PET/CT in the management of patients affected by head and neck tumors: a review of the literature.

Authors:  Giovanni Cammaroto; Natale Quartuccio; Alessandro Sindoni; Francesca Di Mauro; Federico Caobelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-14       Impact factor: 2.503

8.  qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma.

Authors:  Dirk Hasenclever; Lars Kurch; Christine Mauz-Körholz; Andreas Elsner; Thomas Georgi; Hamish Wallace; Judith Landman-Parker; Angelina Moryl-Bujakowska; Michaela Cepelová; Jonas Karlén; Ana Álvarez Fernández-Teijeiro; Andishe Attarbaschi; Alexander Fosså; Jane Pears; Andrea Hraskova; Eva Bergsträsser; Auke Beishuizen; Anne Uyttebroeck; Eckhard Schomerus; Osama Sabri; Dieter Körholz; Regine Kluge
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-07       Impact factor: 9.236

9.  A Virtual Clinical Trial of FDG-PET Imaging of Breast Cancer: Effect of Variability on Response Assessment.

Authors:  Robert L Harrison; Brian F Elston; Robert K Doot; Thomas K Lewellen; David A Mankoff; Paul E Kinahan
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

10.  "Kit like" (18)F labeling method for synthesis of RGD peptide-based PET probes.

Authors:  Shuanglong Liu; Ryan Park; Peter S Conti; Zibo Li
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.